Arrowhead Research | Rentekostnader



Interest Expense On Debt Endring Dato
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Arrowhead Research USD 21.65M 7M 2024-12
Incyte USD 419K 355K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Ligand Pharmaceuticals USD 883K 142K 2024-12
Merck USD 328M 2M 2024-12
Moderna USD 6M 0 2024-12
Novartis USD 275M 11M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
TG Therapeutics USD 10.83M 6.86M 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Xencor -39359000 40.15M 2024-12



Arrowhead Research Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.